KULR Technology (KULR) 10-Q 13 Nov 18 2018 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 09, 2018
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Entity Registrant Name	KULR Technology Group, Inc.
Entity Central Index Key	1,662,684
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		78,021,819
Entity Emerging Growth Company	false
Entity Small Business	true

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current Assets:
Cash	$ 174,350	$ 895,761
Accounts receivable	155,440	151,802
Inventory	13,767	13,767
Prepaid expenses	82,733	106,466
Other current assets	11,089	8,727
Total Current Assets	437,379	1,176,523
Property and equipment, net	47,145	43,493
Total Assets	484,524	1,220,016
Current Liabilities:
Accrued expenses and other current liabilities	491,269	197,713
Accrued expenses and other current liabilities - related parties	203,917	282,597
Deferred revenue	51,158	0
Total Current Liabilities	746,344	480,310
Commitments and contingencies
Stockholders' (Deficiency) Equity:
Preferred stock, $0.0001 par value, 20,000,000 shares authorized; Series A Preferred Stock, 1,000,000 shares designated; None issued and outstanding at September 30, 2018 and December 31, 2017	0	0
Common stock, $0.0001 par value, 100,000,000 shares authorized; 78,021,819 and 77,440,000 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively	7,802	7,744
Additional paid-in capital	5,750,416	5,090,282
Accumulated deficit	(6,020,038)	(4,358,320)
Total Stockholders' (Deficiency) Equity	(261,820)	739,706
Total Liabilities and Stockholders' (Deficiency) Equity	$ 484,524	$ 1,220,016

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2018	Dec. 31, 2017
Preferred Stock, Par Value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value (in dollars per share)	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	78,021,819	77,440,000
Common Stock, Shares, Outstanding	78,021,819	77,440,000
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized	1,000,000	1,000,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue	$ 482,798	$ 15,106	$ 881,929	$ 26,006
Cost of revenue	75,384	52,384	258,801	108,579
Gross Profit (Loss)	407,414	(37,278)	623,128	(82,573)
Operating Expenses:
Research and development	161,194	157,876	399,884	207,504
Research and development - related parties	0	38,767	0	439,824
Selling, general and administrative	461,377	605,473	1,908,635	1,019,835
Total Operating Expenses	622,571	802,116	2,308,519	1,667,163
Loss From Operations	(215,157)	(839,394)	(1,685,391)	(1,749,736)
Other Income (Expense):
Interest (expense) income , net	(269)	142	(502)	(8,114)
Change in fair value of accrued issuable equity	24,175	0	24,175	0
Total Other Income (Expense)	23,906	142	23,673	(8,114)
Net Loss	$ (191,251)	$ (839,252)	$ (1,661,718)	$ (1,757,850)
Net Loss Per Share - Basic and Diluted	$ 0	$ (0.01)	$ (0.02)	$ (0.03)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted	77,785,191	76,843,759	77,513,560	59,570,769

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) - 9 months ended Sep. 30, 2018 - USD ($)		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2017		$ 739,706	$ 7,744	$ 5,090,282	$ (4,358,320)
Balance (shares) at Dec. 31, 2017			77,440,000
Stock-based compensation		307,792	$ 0	307,792	0
Common stock issued for cash, net of issuance costs	[1]	352,400	$ 58	352,342	0
Common stock issued for cash, net of issuance costs (in shares)	[1]		581,819
Net loss		(1,661,718)	$ 0	0	(1,661,718)
Balance at Sep. 30, 2018		$ (261,820)	$ 7,802	$ 5,750,416	$ (6,020,038)
Balance (shares) at Sep. 30, 2018			78,021,819
[1]	Includes gross proceeds of $384,000, less issuance costs of $31,600 ($25,000 of cash and $6,600 of non-cash).

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) (Parenthetical) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2018
Proceeds From Issuance Of Private Placement Gross	$ 384,000	$ 384,000
Stock Issued	6,600
Common Stock [Member]
Payments of Stock Issuance Costs	31,600
Common Stock [Member] | Cash [Member]
Payments of Stock Issuance Costs	$ 25,000	$ 25,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)		9 Months Ended
		Sep. 30, 2018	Sep. 30, 2017
Cash Flows From Operating Activities:
Net loss		$ (1,661,718)	$ (1,757,850)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		11,824	3,374
Change in fair value of accrued issuable equity		(24,175)	0
Stock-based compensation		402,656	411,181
Changes in operating assets and liabilities:
Accounts receivable		(3,638)	(19,106)
Other current receivable		0	30,000
Other current receivable - related parties		0	2,000
Interest receivable - related party		0	2,152
Inventory		0	(15,151)
Prepaid expenses		23,733	(115,945)
Other current assets		(2,362)	861,377
Accrued expenses and other current liabilities		216,267	189,083
Accrued expenses and other current liabilities - related parties		(78,680)	145,300
Deferred revenue		51,158	0
Total Adjustments		596,783	1,494,265
Net Cash Used In Operating Activities		(1,064,935)	(263,585)
Cash Flows From Investing Activities:
Proceeds from loan from related party		0	85,000
Cash acquired in reverse recapitalization		0	1,859,261
Purchases of property and equipment		(15,476)	(36,271)
Net Cash (Used In) Provided By Investing Activities		(15,476)	1,907,990
Cash Flows from Financing Activities:
Proceeds from sale of common stock	[1]	359,000	0
Net Cash Provided By Financing Activities		359,000	0
Net (Decrease) Increase In Cash		(721,411)	1,644,405
Cash - Beginning of Period		895,761	9,087
Cash - End of Period		174,350	1,653,492
Supplemental Disclosures of Cash Flow Information:
Cash paid during the period for: Interest		646	0
Cash paid during the period for: Income taxes		2,400	1,600
Non-cash investing and financing activities:
Common stock equity offering issuance costs		$ 6,600	$ 0
[1]	Includes gross proceeds of $384,000, less withheld issuance costs of $25,000.

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2018
Proceeds From Issuance Of Private Placement Gross	$ 384,000	$ 384,000
Common Stock [Member]
Payments of Stock Issuance Costs	31,600
Common Stock [Member] | Cash [Member]
Payments of Stock Issuance Costs	$ 25,000	$ 25,000

Business Organization, Nature o

Business Organization, Nature of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 Business Organization, Nature of Operations and Basis of Presentation Organization and Operations Effective August 30, 2018, KT High-Tech Marketing, Inc. changed its name to KULR Technology Group, Inc. KULR Technology Group, Inc. ("KUTG") through its wholly-owned subsidiary, KULR Technology Corporation (“KTC”) (collectively referred to as “KULR” or the “Company”), is primarily focused on developing and commercializing its thermal management technologies, which it acquired through assignment from and license with KTC’s co-founder Dr. Timothy Knowles, in the high value, high-performance consumer electronic and energy storage applications. KTC owns proprietary carbon fiber based (Carbon Fiber Velvet or “CFV”) thermal management solutions that it believes are more effective at conducting, dissipating and storing heat generated by an electronic system’s internal components (i.e. semiconductor, integrated circuits “chips”) in comparison to traditional materials, such as copper and aluminum. KTC’s technologies can be applied inside a wide array of electronic applications where heat is often a problem, such as mobile devices, cloud computing, virtual reality platforms, satellites, internet of things, drones, and connected cars. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed consolidated financial statements of the Company as of September 30, 2018 and for the three and nine months then ended. The results of operations for the three and nine months ended September 30, 2018 are not necessarily indicative of the operating results for the full year ending December 31, 2018 or any other period. These condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and related disclosures as of December 31, 2017 and for the year then ended, which were filed with the Securities and Exchange Commission (“SEC”) on Form 10-K on April 17, 2018.

Going Concern and Management's

Going Concern and Management's Plans	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	Note 2 Going Concern and Management’s Plans The Company has not yet achieved profitability and expects to continue to incur cash outflows from operations. It is expected that its research and development and general and administrative expenses will continue to increase and, as a result, the Company will eventually need to generate significant product revenues to achieve profitability. These conditions indicate that there is substantial doubt about the Company’s ability to continue as a going concern within one year after the financial statement issuance date. The Company is currently funding its operations on a month-to-month basis. Although the Company’s management believes that it has access to capital resources, there are currently no commitments in place for new financing at this time and there is no assurance that the Company will be able to obtain funds on commercially acceptable terms, if at all. If the Company is unable to obtain adequate funds on reasonable terms, it may be required to significantly curtail or discontinue operations or obtain funds by entering into financing agreements on unattractive terms. The Company’s operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustment that might become necessary should the Company be unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 3 Summary of Significant Accounting Policies The Company’s significant accounting policies are disclosed in Note 2 – Summary of Significant Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. Since the date of the Annual Report, there have been no material changes to the Company’s significant accounting policies, except as disclosed below. Concentrations of Credit Risk The Company maintains cash with major financial institutions. Cash held in U.S. bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There was an aggregate uninsured cash balance of $611,450 at December 31, 2017. There was no uninsured balance as of September 30, 2018. Customer concentrations are as follows: Revenues Accounts Receivable For the Three Months Ended For the Nine Months Ended As of As of September 30, September 30, September 30, 2018 December 31, 2017 2018 2017 2018 2017 Customer A * * 17 % * * 15 % Customer B * * 12 % * * * Customer C 92 % * 64 % * 92 % 43 % Customer D * * * 42 % * 16 % Customer E * 76 % * 44 % * * Customer F * 24 % * 14 % * * Total 92 % 100 % 93 % 100 % 92 % 74 % * Less than 10% Deferred Offering Costs Deferred offering costs, which primarily consist of direct, incremental professional fees incurred in connection with a debt or equity financing, are capitalized as non-current assets on the balance sheet. Once the financing closes, the Company reclassifies such costs as either discounts to notes payable or as a reduction of proceeds received from equity transactions so that such costs are recorded as a reduction of additional paid-in capital. If the completion of a contemplated financing was deemed to be no longer probable, the related deferred offering costs would be charged to general and administrative expense in the condensed consolidated financial statements. Revenue Recognition On January 1, 2018, the Company adopted ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted ASC 606 for all applicable contracts using the modified retrospective method, which would have required a cumulative-effect adjustment, if any, as of the date of adoption. The adoption of ASC 606 did not have a material impact on the Company's condensed consolidated financial statements as of the date of adoption. As a result, a cumulative-effect adjustment was not required. The Company recognizes revenue primarily from the following different types of contracts: · Product sales · Contract services The following table summarizes our revenue recognized in our condensed consolidated statements of operations: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Product sales $ 482,798 $ 15,106 $ 735,941 $ 26,006 Contract services - - 145,988 - Total revenue $ 482,798 $ 15,106 $ 881,929 $ 26,006 As of September 30, 2018, the Company had $0 and $51,158 contract assets and contract liabilities, respectively, from contracts with customers. The contract liabilities represent payments received from customers for which the Company had not yet satisfied its performance obligation under the contract. As of December 31, 2017, the Company did not have any contract assets or contract liabilities from contracts with customers. During the three and nine months ended September 30, 2018, and 2017, $0 of revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods. Reclassifications Certain prior year balance sheet amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. The following weighted average shares were excluded from basic weighted average common stock outstanding: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Non-vested restricted stock - 596,241 90,812 782,051 Total - 596,241 90,812 782,051 Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of non-vested restricted stock, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: September 30, 2018 2017 Non-vested restricted stock - 500,000 Total - 500,000 Recently Issued Accounting Pronouncements In May 2017, the FASB issued ASU No. 2017-09, “Compensation — Stock Compensation (Topic 718): Scope of Modification Accounting,” (“ASU 2017-09”). ASU 2017-09 provides clarity on the accounting for modifications of stock-based awards. ASU 2017-09 requires adoption on a prospective basis in the annual and interim periods for fiscal years beginning after December 15, 2017 for share-based payment awards modified on or after the adoption date. The Company adopted ASU 2017-09 effective January 1, 2018 and its adoption did not have a material impact on the Company’s condensed consolidated financial statements. In June 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for nonemployee share-based payments. Currently, the accounting requirements for nonemployee and employee share-based payment transactions are significantly different. ASU 2018-07 expands the scope of Topic 718, Compensation — Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity — Equity-Based Payments to Nonemployees. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company early adopted ASU 2018-07 effective April 1, 2018. The adoption of this ASU did not have a material impact on the Company’s condensed consolidated financial statements. In July 2018, the FASB issued ASU No. 2018-09, “Codification Improvements” (“ASU 2018-09”). These amendments provide clarifications and corrections to certain ASC subtopics including the following: Income Statement - Reporting Comprehensive Income – Overall (Topic 220-10), Debt - Modifications and Extinguishments (Topic 470-50), Distinguishing Liabilities from Equity – Overall (Topic 480-10), Compensation - Stock Compensation - Income Taxes (Topic 718-740), Business Combinations - Income Taxes (Topic 805-740), Derivatives and Hedging – Overall (Topic 815-10), and Fair Value Measurement – Overall (Topic 820-10). The majority of the amendments in ASU 2018-09 will be effective in annual periods beginning after December 15, 2018. The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements. In July 2018, the FASB issued Accounting Standards Update No. 2018-10, “Codification Improvements to Topic 842, Leases,” (“ASU 2018-10”). The amendments in ASU 2018-10 are to address stakeholders’ questions about how to apply certain aspects of the new guidance in ASC 842. The clarifications address the rate implicit in the lease, impairment of the net investment in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. The amendments in ASC Topic 842 are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company is currently in the process of evaluating its lease assets and lease liabilities to be recorded as of January 1, 2019. The Company continues to evaluate other provisions of the updated guidance and expects to complete its analysis by December 31, 2018. In July 2018, the FASB issued Accounting Standards Update No. 2018-11, “Leases (Topic 842): Targeted Improvements,” (“ASU 2018-11”). The amendments in ASU 2018-11 related to transition relief on comparative reporting at adoption affect all entities with lease contracts that choose the additional transition method and separating components of a contract affect only lessors whose lease contracts qualify for the practical expedient. The amendments in ASC Topic 842 are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company is currently in the process of evaluating its lease assets and lease liabilities to be recorded as of January 1, 2019. The Company continues to evaluate other provisions of the updated guidance and expects to complete its analysis by December 31, 2018. In August 2018, the FASB issued Accounting Standards Update No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments are effective for all entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements.

Prepaid Expenses

Prepaid Expenses	9 Months Ended
	Sep. 30, 2018
Prepaid Expense, Current [Abstract]
Prepaid Expenses Disclosure [Text Block]	Note 4 Prepaid Expenses As of September 30, 2018 and December 31, 2017, prepaid expenses consisted of the following: September 30, 2018 December 31, 2017 (unaudited) Business development services $ - $ 40,000 Research and development services 27,616 25,000 Professional fees 16,991 10,000 Filing fees 12,500 - Insurance 9,750 - Other 15,876 31,466 Total prepaid expenses $ 82,733 $ 106,466

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Sep. 30, 2018
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	Note 5 Accrued Expenses and Other Current Liabilities As of September 30, 2018 and December 31, 2017, accrued expenses and other current liabilities consisted of the following: September 30, 2018 December 31, 2017 (unaudited) Accrued legal and professional fees $ 100,379 $ 71,241 Accrued payroll and vacation 80,776 69,425 Payroll and income tax payable 107,601 14,223 Accrued research and development expenses 41,819 14,611 Credit card payable 6,266 110 Accrued issuable equity 77,289 1,104 Other 77,139 26,999 Total accrued expenses and other current liabilities $ 491,269 $ 197,713 The Company has agreed to issue an aggregate of 117,104 shares of common stock for legal and consulting fees. See Note 7 – Stockholders’ Equity – Stock-Based Compensation for details of related expense recognized. As of September 30, 2018, the shares had not been issued and, as a result, $77,289 of accrued issuable equity is included within accrued expenses and other current liabilities.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2018
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 6 Related Party Transactions Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities – related parties consist of: (i) a liability of $142,269 and $254,344 as of September 30, 2018 and December 31, 2017, respectively, to Energy Science Laboratories, Inc. (“ESLI”), a company controlled by the Company’s Chief Technology Officer (“CTO”), in connection with consulting services provided to the Company associated with the development of the Company’s CFV thermal management solutions; and (ii) a liability of $61,647 and $28,253 as of September 30, 2018 and December 31, 2017, respectively, to the Company’s Chief Executive Officer (“CEO”) in connection with Company-related travel and entertainment expenses incurred by the CEO. Consulting Agreements During the three and nine months ended September 30, 2017, the Company recorded aggregate expense of $0 and $65,000 (of which, $32,500 and $32,500 was included within research and development expenses and selling, general and administrative expenses, respectively), respectively, related to consulting agreements with its CEO and CTO, which were terminated in connection with the closing of the Share Exchange Agreement on June 19, 2017. During the three and nine months ended September 30, 2017, the Company recorded research and development expense of $38,767 and $407,324, respectively, related to consulting services provided to the Company by ESLI associated with the development of the Company’s CFV thermal management solutions. There were no such costs recorded in the three and nine months ended September 30, 2018. ESLI is controlled by the Company’s CTO.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2018
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 7 Stockholders' Equity Private Placement of Common Stock During the three months ended September 30, 2018, the Company sold an aggregate of 581,819 shares of common stock at $0.66 per share to accredited investors for aggregate gross and net proceeds of $384,000 and $352,400, respectively. Of the $31,600 of issuance costs, $25,000 were cash costs and $6,600 were non-cash costs. Stock-Based Compensation During the three and nine months ended September 30, 2018, the Company recognized stock-based compensation expense of $94,864 and $402,656, respectively, and during the three and nine months ended September 30, 2017, the Company recognized stock-based compensation expense of $187,023 and $411,181, respectively, related to restricted common stock awards which is included within general and administrative expenses on the condensed consolidated statements of operations. As of September 30, 2018, there was no unrecognized stock-based compensation expense. Equity Incentive Plan On August 15 and November 5, 2018, the Board of Directors and a majority of the Company’s shareholders, respectively, approved the 2018 KULR Technology Group Equity Incentive Plan (the “2018 Plan”) . Under the 2018 Plan, 15,000,000 shares of common stock of the Company are authorized for issuance. The 2018 Plan provides for the issuance of incentive stock options, non-statutory stock options, rights to purchase common stock, stock appreciation rights, restricted stock and restricted stock units to employees, directors and consultants of the Company and its affiliates. The 2018 Plan requires the exercise price of stock options to be not less than the fair value of the Company’s common stock on the date of grant.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 8 Commitments and Contingencies Patent License Agreement On March 21, 2018, the Company entered into an agreement with the National Renewable Energy Laboratory (“NREL”) granting the Company an exclusive license to commercialize its patented Internal Short Circuit technology. The agreement shall be effective for as long as the licensed patents are enforceable, subject to certain early termination provisions specified in the agreement. In consideration, the Company agreed to pay to NREL the following: (i) a cash payment of $12,000 payable over one year, and (ii) royalties ranging from 1.5% to 3.75% on the net sales price of the licensed products, as defined in the agreement, with minimum annual royalty payments ranging from $0 to $7,500. In addition, the Company shall use commercially reasonable efforts to bring the licensed products to market through a commercialization program that requires that certain milestones be met, as specified in the agreement. As of the date of filing, there had been no sales of the licensed products, such that no royalties had been earned.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2018
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 9 Subsequent Events Shareholder Consent On November 5, 2018, the Company received a written consent of the stockholders representing 78.4% of the issued and outstanding securities of the Company entitled to vote on matters of the stockholders to take the following actions: (i) to amend the Company’s certificate of incorporation with the Delaware Secretary of State increasing the number of authorized shares of the Company’s common stock from 100,000,000 shares to 500,000,000 shares; (ii) to approve, ratify and adopt the Company’s 2018 Equity Incentive Plan, pursuant to which the Company may award up to 15,000,000 shares of the Company’s common stock to employees, nonemployee officers and directors and consultants for the purpose of, among other things, motivating such persons to put forth their maximum efforts for the Company’s growth, profitability and success; and (iii) to approve and authorize, as a measure to protect the progress of the Company by vesting voting control of the Company in its Chief Executive Officer, Michael Mo, the issuance of 1,000,000 shares of the Company’s Series A Voting Preferred Stock to Mr. Mo.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk The Company maintains cash with major financial institutions. Cash held in U.S. bank institutions is currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 at each institution. There was an aggregate uninsured cash balance of $611,450 at December 31, 2017. There was no uninsured balance as of September 30, 2018. Customer concentrations are as follows: Revenues Accounts Receivable For the Three Months Ended For the Nine Months Ended As of As of September 30, September 30, September 30, 2018 December 31, 2017 2018 2017 2018 2017 Customer A * * 17 % * * 15 % Customer B * * 12 % * * * Customer C 92 % * 64 % * 92 % 43 % Customer D * * * 42 % * 16 % Customer E * 76 % * 44 % * * Customer F * 24 % * 14 % * * Total 92 % 100 % 93 % 100 % 92 % 74 % * Less than 10%
Deffered Offering Costs Policy [Policy Text Block]	Deferred Offering Costs Deferred offering costs, which primarily consist of direct, incremental professional fees incurred in connection with a debt or equity financing, are capitalized as non-current assets on the balance sheet. Once the financing closes, the Company reclassifies such costs as either discounts to notes payable or as a reduction of proceeds received from equity transactions so that such costs are recorded as a reduction of additional paid-in capital. If the completion of a contemplated financing was deemed to be no longer probable, the related deferred offering costs would be charged to general and administrative expense in the condensed consolidated financial statements.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition On January 1, 2018, the Company adopted ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted ASC 606 for all applicable contracts using the modified retrospective method, which would have required a cumulative-effect adjustment, if any, as of the date of adoption. The adoption of ASC 606 did not have a material impact on the Company's condensed consolidated financial statements as of the date of adoption. As a result, a cumulative-effect adjustment was not required. The Company recognizes revenue primarily from the following different types of contracts: · Product sales · Contract services The following table summarizes our revenue recognized in our condensed consolidated statements of operations: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Product sales $ 482,798 $ 15,106 $ 735,941 $ 26,006 Contract services - - 145,988 - Total revenue $ 482,798 $ 15,106 $ 881,929 $ 26,006 As of September 30, 2018, the Company had $0 and $51,158 contract assets and contract liabilities, respectively, from contracts with customers. The contract liabilities represent payments received from customers for which the Company had not yet satisfied its performance obligation under the contract. As of December 31, 2017, the Company did not have any contract assets or contract liabilities from contracts with customers. During the three and nine months ended September 30, 2018, and 2017, $0 of revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods.
Reclassification, Policy [Policy Text Block]	Reclassifications Certain prior year balance sheet amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.
Earnings Per Share, Policy [Policy Text Block]	Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. The following weighted average shares were excluded from basic weighted average common stock outstanding: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Non-vested restricted stock - 596,241 90,812 782,051 Total - 596,241 90,812 782,051 Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of non-vested restricted stock, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: September 30, 2018 2017 Non-vested restricted stock - 500,000 Total - 500,000
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements In May 2017, the FASB issued ASU No. 2017-09, “Compensation — Stock Compensation (Topic 718): Scope of Modification Accounting,” (“ASU 2017-09”). ASU 2017-09 provides clarity on the accounting for modifications of stock-based awards. ASU 2017-09 requires adoption on a prospective basis in the annual and interim periods for fiscal years beginning after December 15, 2017 for share-based payment awards modified on or after the adoption date. The Company adopted ASU 2017-09 effective January 1, 2018 and its adoption did not have a material impact on the Company’s condensed consolidated financial statements. In June 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for nonemployee share-based payments. Currently, the accounting requirements for nonemployee and employee share-based payment transactions are significantly different. ASU 2018-07 expands the scope of Topic 718, Compensation — Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity — Equity-Based Payments to Nonemployees. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company early adopted ASU 2018-07 effective April 1, 2018. The adoption of this ASU did not have a material impact on the Company’s condensed consolidated financial statements. In July 2018, the FASB issued ASU No. 2018-09, “Codification Improvements” (“ASU 2018-09”). These amendments provide clarifications and corrections to certain ASC subtopics including the following: Income Statement - Reporting Comprehensive Income – Overall (Topic 220-10), Debt - Modifications and Extinguishments (Topic 470-50), Distinguishing Liabilities from Equity – Overall (Topic 480-10), Compensation - Stock Compensation - Income Taxes (Topic 718-740), Business Combinations - Income Taxes (Topic 805-740), Derivatives and Hedging – Overall (Topic 815-10), and Fair Value Measurement – Overall (Topic 820-10). The majority of the amendments in ASU 2018-09 will be effective in annual periods beginning after December 15, 2018. The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements. In July 2018, the FASB issued Accounting Standards Update No. 2018-10, “Codification Improvements to Topic 842, Leases,” (“ASU 2018-10”). The amendments in ASU 2018-10 are to address stakeholders’ questions about how to apply certain aspects of the new guidance in ASC 842. The clarifications address the rate implicit in the lease, impairment of the net investment in the lease, lessee reassessment of lease classification, lessor reassessment of lease term and purchase options, variable payments that depend on an index or rate and certain transition adjustments. The amendments in ASC Topic 842 are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company is currently in the process of evaluating its lease assets and lease liabilities to be recorded as of January 1, 2019. The Company continues to evaluate other provisions of the updated guidance and expects to complete its analysis by December 31, 2018. In July 2018, the FASB issued Accounting Standards Update No. 2018-11, “Leases (Topic 842): Targeted Improvements,” (“ASU 2018-11”). The amendments in ASU 2018-11 related to transition relief on comparative reporting at adoption affect all entities with lease contracts that choose the additional transition method and separating components of a contract affect only lessors whose lease contracts qualify for the practical expedient. The amendments in ASC Topic 842 are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company is currently in the process of evaluating its lease assets and lease liabilities to be recorded as of January 1, 2019. The Company continues to evaluate other provisions of the updated guidance and expects to complete its analysis by December 31, 2018. In August 2018, the FASB issued Accounting Standards Update No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments are effective for all entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Customer concentrations are as follows: Revenues Accounts Receivable For the Three Months Ended For the Nine Months Ended As of As of September 30, September 30, September 30, 2018 December 31, 2017 2018 2017 2018 2017 Customer A * * 17 % * * 15 % Customer B * * 12 % * * * Customer C 92 % * 64 % * 92 % 43 % Customer D * * * 42 % * 16 % Customer E * 76 % * 44 % * * Customer F * 24 % * 14 % * * Total 92 % 100 % 93 % 100 % 92 % 74 % * Less than 10%
Revenue from External Customers by Products and Services [Table Text Block]	The following table summarizes our revenue recognized in our condensed consolidated statements of operations: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Product sales $ 482,798 $ 15,106 $ 735,941 $ 26,006 Contract services - - 145,988 - Total revenue $ 482,798 $ 15,106 $ 881,929 $ 26,006
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. The following weighted average shares were excluded from basic weighted average common stock outstanding: For the Three Months Ended For the Nine Months Ended September 30, September 30, 2018 2017 2018 2017 Non-vested restricted stock - 596,241 90,812 782,051 Total - 596,241 90,812 782,051 Diluted net loss per common share is computed by dividing net loss by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of non-vested restricted stock, if not anti-dilutive. The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive: September 30, 2018 2017 Non-vested restricted stock - 500,000 Total - 500,000

Prepaid Expenses (Tables)

Prepaid Expenses (Tables)	9 Months Ended
	Sep. 30, 2018
Prepaid Expense, Current [Abstract]
Schedule of Prepaid Expenses [Table Text Block]	As of September 30, 2018 and December 31, 2017, prepaid expenses consisted of the following: September 30, 2018 December 31, 2017 (unaudited) Business development services $ - $ 40,000 Research and development services 27,616 25,000 Professional fees 16,991 10,000 Filing fees 12,500 - Insurance 9,750 - Other 15,876 31,466 Total prepaid expenses $ 82,733 $ 106,466

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Sep. 30, 2018
Accounts Payable and Accrued Liabilities, Current [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	As of September 30, 2018 and December 31, 2017, accrued expenses and other current liabilities consisted of the following: September 30, 2018 December 31, 2017 (unaudited) Accrued legal and professional fees $ 100,379 $ 71,241 Accrued payroll and vacation 80,776 69,425 Payroll and income tax payable 107,601 14,223 Accrued research and development expenses 41,819 14,611 Credit card payable 6,266 110 Accrued issuable equity 77,289 1,104 Other 77,139 26,999 Total accrued expenses and other current liabilities $ 491,269 $ 197,713

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details)		3 Months Ended				9 Months Ended
		Sep. 30, 2018		Sep. 30, 2017		Sep. 30, 2018		Sep. 30, 2017		Dec. 31, 2017
Concentration Risk	[1]
Revenues [Member]
Concentration Risk, Percentage		92.00%		100.00%		93.00%		100.00%
Accounts Receivable [Member]
Concentration Risk		92.00%				92.00%				74.00%
Customer A [Member] | Revenues [Member]
Concentration Risk, Percentage			[1]		[1]	17.00%			[1]
Customer A [Member] | Accounts Receivable [Member]
Concentration Risk										15.00%
Customer B [Member] | Revenues [Member]
Concentration Risk, Percentage			[1]		[1]	12.00%			[1]
Customer B [Member] | Accounts Receivable [Member]
Concentration Risk	[1]
Customer C [Member] | Revenues [Member]
Concentration Risk, Percentage		92.00%			[1]	64.00%			[1]
Customer C [Member] | Accounts Receivable [Member]
Concentration Risk		92.00%				92.00%				43.00%
Customer D [Member] | Revenues [Member]
Concentration Risk, Percentage			[1]		[1]		[1]	42.00%
Customer D [Member] | Accounts Receivable [Member]
Concentration Risk			[1]				[1]			16.00%
Customer E [Member] | Revenues [Member]
Concentration Risk, Percentage			[1]	76.00%			[1]	44.00%
Customer E [Member] | Accounts Receivable [Member]
Concentration Risk	[1]
Customer F [Member] | Revenues [Member]
Concentration Risk, Percentage			[1]	24.00%			[1]	14.00%
Customer F [Member] | Accounts Receivable [Member]
Concentration Risk	[1]
[1]	Less than 10%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Total revenue	$ 482,798	$ 15,106	$ 881,929	$ 26,006
Product sales [Member]
Total revenue	482,798	15,106	735,941	26,006
Contract services [Member]
Total revenue	$ 0	$ 0	$ 145,988	$ 0

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details 2) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Earnings per share basic [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	596,241	90,812	782,051
Earnings per share diluted [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			0	500,000
Restricted Stock [Member] | Earnings per share basic [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	596,241	90,812	782,051
Restricted Stock [Member] | Earnings per share diluted [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			0	500,000

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Cash, FDIC Insured Amount	$ 250,000		$ 250,000
Cash, Uninsured Amount	0		0		$ 611,450
Contract with Customer, Asset, Net	0		0
Contract with Customer, Liability	51,158		51,158
Contract with Customer, Liability, Revenue Recognized	$ 0	$ 0	$ 0	$ 0

Prepaid Expenses (Details)

Prepaid Expenses (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Total prepaid expenses	$ 82,733	$ 106,466
Business development services [Member]
Business development services	0	40,000
Research and development services	27,616	25,000
Professional fees	16,991	10,000
Filing fees	12,500	0
Insurance	9,750	0
Other	15,876	31,466
Total prepaid expenses	$ 82,733	$ 106,466

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Accrued legal and professional fees	$ 100,379	$ 71,241
Accrued payroll and vacation	80,776	69,425
Payroll and income tax payable	107,601	14,223
Accrued research and development expenses	41,819	14,611
Credit card payable	6,266	110
Accrued issuable equity	77,289	1,104
Other	77,139	26,999
Total accrued expenses and other current liabilities	$ 491,269	$ 197,713

Accrued Expenses and Other Cu_4

Accrued Expenses and Other Current Liabilities (Details Textual) - USD ($)	1 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Accrued issuable Equity	$ 77,289	$ 1,104
Share To Be Issued Legal And Consulting Fees	117,104

Related Party Transactions (Det

Related Party Transactions (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Related Party Transaction [Line Items]
Due to Other Related Parties, Current	$ 203,917		$ 203,917		$ 282,597
Other Research and Development Expense	0	$ 38,767	0	$ 439,824
Consulting Agreements [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party		0		65,000
Consulting Agreements [Member] | Research and Development Expense [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party		32,500
Consulting Agreements [Member] | Selling, General and Administrative Expenses [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party		32,500
Chief Technology Officer CTO [Member]
Related Party Transaction [Line Items]
Due to Other Related Parties, Current	142,269		142,269		254,344
Energy Science Laboratories, Inc ESLI [Member]
Related Party Transaction [Line Items]
Other Research and Development Expense		$ 38,767		$ 407,324
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Due to Other Related Parties, Current	$ 61,647		$ 61,647		$ 28,253

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018		Sep. 30, 2017	Nov. 05, 2018
Stock Issued During Period, Value, New Issues		$ 352,400		$ 352,400	[1]
Proceeds From Issuance Of Private Placement Gross		384,000		384,000
Stock Issued		6,600
General and Administrative Expense [Member]
Allocated Share-based Compensation Expense		$ 94,864	$ 187,023	$ 402,656		$ 411,181
Subsequent Event [Member] | 2018 Group Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized							15,000,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues		581,819		581,819	[1]
Stock Issued During Period, Value, New Issues	[1]			$ 58
Sale of Stock, Price Per Share		$ 0.66		$ 0.66
Payments of Stock Issuance Costs		$ 31,600
Common Stock [Member] | Cash [Member]
Payments of Stock Issuance Costs		$ 25,000		$ 25,000
[1]	Includes gross proceeds of $384,000, less issuance costs of $31,600 ($25,000 of cash and $6,600 of non-cash).

Commitments and Contingencies (

Commitments and Contingencies (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Research and Development Expense	$ 161,194	$ 157,876	$ 399,884	$ 207,504
License [Member]
Research and Development Expense			$ 12,000
Minimum [Member]
Royalty Rate			1.50%
Royalty Expense			$ 0
Maximum [Member]
Royalty Rate			3.75%
Royalty Expense			$ 7,500

Subsequent Events (Details Text

Subsequent Events (Details Textual) - shares	Nov. 05, 2018	Sep. 30, 2018	Dec. 31, 2017
Subsequent Event [Line Items]
Common Stock, Shares Authorized		100,000,000	100,000,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Common Stock, Shares Authorized	500,000,000
Percentage of Issued and Outstanding Securities	78.40%
Subsequent Event [Member] | Series A Preferred Stock [Member]
Subsequent Event [Line Items]
Shares to be Issued	1,000,000
Subsequent Event [Member] | Two Thousand and Eighteen Group Equity Incentive Plan [Member]
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	15,000,000